Claret Medical chases FDA win with $18M Series B for cerebral protection device

California device maker Claret Medical plans to use its new funds to complete a U.S. pivotal trial of its Sentinel cerebral protection system.

Claret Medical said today that it secured up to $18 million in Series B financing it plans to use to make progress toward the U.S. market.

Claret Medical Inc., Easton Capital, Lightstone Ventures, Sante Ventures

News Well, Funding Roundup, Replacement Heart Valves

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1s5TK67